BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6037073)

  • 21. Potential antitumor agents. Derivatives of 2-hydrazino-5-nitropyridine.
    Prescott B; Caldes G
    J Pharm Sci; 1970 Jan; 59(1):101-4. PubMed ID: 5411311
    [No Abstract]   [Full Text] [Related]  

  • 22. Derivatives of fluorene. XXX. Rearrangement and antitumor activities of some 9-oxofluorene oximes. 6(5H)-Phenanthridinones. I.
    Pan HL; Fletcher TL
    J Med Chem; 1969 Sep; 12(5):822-5. PubMed ID: 5812195
    [No Abstract]   [Full Text] [Related]  

  • 23. Organic fluorine compounds. 3. Action of perchloryl fluoride on substituted ethyl cyanoacetates and animal toxicities of the fluorinated products.
    Gershon H; Schulman SG; Spevack AD
    J Med Chem; 1967 Jul; 10(4):536-41. PubMed ID: 4292146
    [No Abstract]   [Full Text] [Related]  

  • 24. Imidazoles. II. 5(or 4)-(Monosubstituted triazeno)imidazole-4(or 5)-carboxamides.
    Shealy YF; Krauth CA
    J Med Chem; 1966 Jan; 9(1):35-8. PubMed ID: 5958957
    [No Abstract]   [Full Text] [Related]  

  • 25. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1965 Oct; 25(9):1454-8. PubMed ID: 5862990
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on chemotherapeutic agents. 3. A synthesis of 3-phenypurine derivatives.
    Kishikawa T; Yuki H
    Chem Pharm Bull (Tokyo); 1966 Dec; 14(12):1365-70. PubMed ID: 5977957
    [No Abstract]   [Full Text] [Related]  

  • 27. Alpha-(N)-formylheteroaromatic thiosemicarbazones. Inhibition of tumor-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activity.
    French FA; Blanz EJ; Shaddix SC; Brockman RW
    J Med Chem; 1974 Feb; 17(2):172-81. PubMed ID: 4809253
    [No Abstract]   [Full Text] [Related]  

  • 28. Pyrimidines. XVI. 2,4,5-Triaminopyrimidines and related compounds.
    O'Brien DE; Noell CW; Robins RK; Cheng CC
    J Med Chem; 1966 Jan; 9(1):121-6. PubMed ID: 6006225
    [No Abstract]   [Full Text] [Related]  

  • 29. Further evaluation of bimolane and analogs as potential antitumor agents.
    Ren YF; Otter GM; Schmid FA
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):493-7. PubMed ID: 3859415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antitumour activity of a series of benzothiophenes.
    Hellmann K; Marshall PG; Stayt S
    Biochem Pharmacol; 1967 Apr; 16(4):681-7. PubMed ID: 6033788
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of ethidium bromide against transplantable tumors in mice and rats.
    Kramer MJ; Grunberg E
    Chemotherapy; 1973 Oct; 19(4):254-8. PubMed ID: 4801160
    [No Abstract]   [Full Text] [Related]  

  • 32. Nucleosides. XXIX. 1-beta-D-arabinofuranosyl-5-fluorocytosine and related arabino nucleosides.
    Fox JJ; Miller N; Wempen I
    J Med Chem; 1966 Jan; 9(1):101-5. PubMed ID: 5958936
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening data from the Caner Chemotherapy National Service Center Screening Laboratories. XXIX.
    Leiter J; Abbott BJ; Schepartz SA
    Cancer Res; 1965 Dec; 25(11 Pt 2):1779-2061. PubMed ID: 5856668
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis of potential antineoplastic agents. Substituted phenylcyclohexenes.
    Core SK; Lotspeich FJ
    J Med Chem; 1969 Mar; 12(2):334-6. PubMed ID: 4181946
    [No Abstract]   [Full Text] [Related]  

  • 35. The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1966 Aug; 26(8):1638-40. PubMed ID: 5923162
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis of possible cancer chemotherapeutic agents based on enzyme rationale. VI. Allylamine derivatives.
    Tsou KC; Damle SB; Crichlow RW; Ravdin RG; Blunt HW
    J Pharm Sci; 1967 Apr; 56(4):484-8. PubMed ID: 6034545
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].
    Shorin VA; Averbukh LA; Bazhanov VS; Lepeshkina GN; Grinshteĭn AM
    Antibiotiki; 1972 Aug; 17(8):675-80. PubMed ID: 4678532
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
    Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
    Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
    [No Abstract]   [Full Text] [Related]  

  • 40. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XLI. Plant extracts.
    Abbott BJ; Hartwell JL; Leiter J; Spetzman LA; Schepartz SA
    Cancer Res; 1967 May; 27(5 Pt 2):364-527. PubMed ID: 4290629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.